China's LEAPER RNA Editing Platform Achieves First Clinical Milestone in Duchenne Muscular Dystrophy | Antwort

China's LEAPER RNA Editing Platform Achieves First Clinical Milestone in Duchenne Muscular Dystrophy | Antwort | Studio Global AI